Inhibikase Therapeutics Issues Letter to Shareholders and Pr

BOSTON and ATLANTA, April 18, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's...

Related Keywords

Atlanta , Georgia , United States , Boston , Massachusetts , Miltonh Werner , Alex Lobo , Inhibikase Or Company , Nasdaq , Linkedin , Sternir Inc , Exchange Commission , Institute Of The National Institutes Health , National Institute Of Neurological Disease , Company Contact , Drug Administration For Ik , Facebook , Inhibikase Therapeutics Inc , Youtube , Abelson Tyrosine Kinases , Fellow Shareholders , Inhibikase Therapeutics , Drug Administration , Multiple System Atrophy , National Institute , Neurological Disease , National Institutes , Pulmonary Arterial Hypertension , Abelson Tyrosine Kinase , Abelson Tyrosine , Private Securities Litigation Reform Act ,